Citation

Pérez-Esparza R, Kobayashi-Romero LF, García-Mendoza AM, Lamas-Aguilar RM, Fonseca-Perezamador A. Acta Psychiatr. Scand. 2019; 140(2): 182-183.

Copyright

(Copyright © 2019, John Wiley and Sons)

DOI

10.1111/acps.13063

PMID

31251388

Abstract

[Abstract unavailable]

Language: en

Keywords

Humans; Risk Factors; United States; Substance-Related Disorders; Suicidal Ideation; United States Food and Drug Administration; Antidepressive Agents; Ketamine; Brain-Derived Neurotrophic Factor; Depressive Disorder, Treatment-Resistant; Administration, Intranasal; Receptors, N-Methyl-D-Aspartate; Anesthetics, Dissociative